PR

Professor Robinson

Ecofibre Limited | Non-Executive Director
Mr Robinson, a practising Endocrinologist at Sydney's Royal North Shore Hospital, is Former Dean of University of Sydney's Sydney Medical School. Professor Robinson has been the head of the Cancer Genetics Unit at the Kolling Institute of Medical Research, Royal North Shore Hospital since 1989. Since 2001, Professor Robinson has been Chairman of Hoc Mai Foundation, a program in medical and health education and exchange with Vietnam. He is a Non-Executive Director of Cochlear Limited, Lorica and QBiotics Group Limited. He is a Board Member of the Woolcock Institute, is Chair of National Health and Medical Research Council and Chair of the Medical Benefits Review Taskforce. Prof Robinson is Chair of the Science, Technology and Medical Committee.

Companies and Roles

Company
Title
Tenure
Since
EOF
EOF
Ecofibre Limited
  • Non-Executive Director
4yrs, 3mthMar 2021
COH
COH
Cochlear Limited
  • Non-Executive Director
8yrs, 6mthDec 2016
MYX
MYX
Mayne Pharma Group Limited
  • Non-Executive Director
10yrs, 9mthAug 2014

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
EOF
EOF
Ecofibre Limited
23/10/241,222,281N/A0N/A
COH
COH
Cochlear Limited
30/06/24341,730N/AN/AN/A
MYX
MYX
Mayne Pharma Group Limited
30/06/2431,745N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
EOF
EOF
Ecofibre Limited
23/10/24
Buy
1,025,614$0.049$50,241On-market trade
EOF
EOF
Ecofibre Limited
07/10/24
Expiry
144,750$0.034$4,921Options expired
EOF
EOF
Ecofibre Limited
21/12/23
Issued
166,667$0.180$30,000Issue of securities
COH
COH
Cochlear Limited
24/10/22
Buy
102$194.863$19,876On-market trade
EOF
EOF
Ecofibre Limited
13/12/21
Buy
30,000$0.550$16,500On-market trade